S
Shenzhen Lihexing Co Ltd
SZSE:301013
Shenzhen Lihexing Co Ltd
SZSE:301013
Price:
25.28
CNY
1.98%
Market Closed
Market Cap:
¥5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shenzhen Lihexing Co Ltd
SZSE:301013
|
CN |
|
Casa Holdings Ltd
SGX:C04
|
SG |
|
Immunotech Biopharm Ltd
HKEX:6978
|
CN |
Income Statement
Earnings Waterfall
Shenzhen Lihexing Co Ltd
Shenzhen Lihexing Co Ltd
Income Statement
Shenzhen Lihexing Co Ltd
Shenzhen Lihexing Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
3
|
3
|
6
|
7
|
8
|
10
|
9
|
9
|
12
|
12
|
12
|
13
|
0
|
6
|
0
|
0
|
|
| Revenue |
474
N/A
|
432
-9%
|
467
+8%
|
426
-9%
|
433
+2%
|
436
+1%
|
366
-16%
|
389
+6%
|
307
-21%
|
346
+13%
|
359
+4%
|
391
+9%
|
470
+20%
|
542
+15%
|
571
+5%
|
537
-6%
|
577
+7%
|
486
-16%
|
494
+2%
|
545
+10%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(327)
|
(299)
|
(321)
|
(303)
|
(290)
|
(299)
|
(269)
|
(283)
|
(249)
|
(274)
|
(294)
|
(320)
|
(419)
|
(467)
|
(479)
|
(451)
|
(462)
|
(396)
|
(439)
|
(514)
|
|
| Gross Profit |
147
N/A
|
133
-9%
|
146
+9%
|
123
-15%
|
143
+16%
|
137
-4%
|
96
-30%
|
106
+10%
|
57
-46%
|
71
+25%
|
65
-8%
|
72
+9%
|
51
-29%
|
75
+48%
|
92
+23%
|
86
-7%
|
115
+34%
|
90
-22%
|
55
-39%
|
31
-43%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(55)
|
(71)
|
(77)
|
(84)
|
(100)
|
(99)
|
(101)
|
(101)
|
(112)
|
(110)
|
(113)
|
(104)
|
(105)
|
(123)
|
(112)
|
(118)
|
(101)
|
(90)
|
(105)
|
(108)
|
|
| Selling, General & Administrative |
(42)
|
(48)
|
(55)
|
(58)
|
(68)
|
(66)
|
(67)
|
(70)
|
(71)
|
(69)
|
(68)
|
(64)
|
(69)
|
(77)
|
(68)
|
(72)
|
(61)
|
(55)
|
(64)
|
(64)
|
|
| Research & Development |
(27)
|
(31)
|
(32)
|
(38)
|
(33)
|
(43)
|
(45)
|
(41)
|
(46)
|
(46)
|
(48)
|
(47)
|
(45)
|
(48)
|
(43)
|
(43)
|
(48)
|
(45)
|
(46)
|
(47)
|
|
| Depreciation & Amortization |
(2)
|
(1)
|
(1)
|
0
|
(14)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
16
|
9
|
11
|
14
|
15
|
11
|
11
|
10
|
11
|
4
|
2
|
8
|
16
|
2
|
(0)
|
(3)
|
14
|
10
|
5
|
3
|
|
| Operating Income |
92
N/A
|
62
-32%
|
69
+10%
|
39
-43%
|
44
+11%
|
38
-13%
|
(5)
N/A
|
5
N/A
|
(55)
N/A
|
(39)
+29%
|
(48)
-24%
|
(32)
+33%
|
(54)
-68%
|
(48)
+11%
|
(20)
+59%
|
(32)
-60%
|
14
N/A
|
(0)
N/A
|
(50)
-22 772%
|
(77)
-55%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
5
|
4
|
2
|
1
|
2
|
2
|
(0)
|
0
|
(2)
|
(4)
|
(3)
|
(4)
|
(9)
|
(11)
|
(12)
|
(13)
|
(12)
|
(13)
|
(14)
|
(15)
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
1
|
1
|
1
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(2)
|
|
| Total Other Income |
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(1)
|
(1)
|
2
|
2
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
96
N/A
|
65
-32%
|
69
+7%
|
39
-44%
|
46
+18%
|
40
-12%
|
(5)
N/A
|
5
N/A
|
(60)
N/A
|
(45)
+24%
|
(51)
-13%
|
(36)
+29%
|
(62)
-69%
|
(58)
+6%
|
(32)
+44%
|
(46)
-41%
|
2
N/A
|
(13)
N/A
|
(63)
-374%
|
(93)
-47%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(11)
|
(6)
|
(6)
|
(1)
|
1
|
1
|
9
|
7
|
17
|
16
|
18
|
16
|
22
|
22
|
14
|
17
|
2
|
5
|
17
|
17
|
|
| Income from Continuing Operations |
85
|
59
|
63
|
38
|
47
|
41
|
4
|
12
|
(43)
|
(29)
|
(34)
|
(21)
|
(39)
|
(36)
|
(18)
|
(29)
|
4
|
(9)
|
(46)
|
(76)
|
|
| Income to Minority Interest |
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
3
|
4
|
3
|
2
|
2
|
|
| Net Income (Common) |
85
N/A
|
59
-30%
|
64
+7%
|
39
-40%
|
48
+24%
|
42
-12%
|
5
-89%
|
14
+193%
|
(41)
N/A
|
(28)
+34%
|
(32)
-15%
|
(20)
+38%
|
(38)
-93%
|
(34)
+10%
|
(16)
+54%
|
(25)
-61%
|
7
N/A
|
(5)
N/A
|
(44)
-723%
|
(74)
-67%
|
|
| EPS (Diluted) |
0.36
N/A
|
0.25
-31%
|
0.52
+108%
|
0.17
-67%
|
0.23
+35%
|
0.18
-22%
|
0.01
-94%
|
0.05
+400%
|
-0.18
N/A
|
-0.13
+28%
|
-0.14
-8%
|
-0.09
+36%
|
-0.16
-78%
|
-0.15
+6%
|
-0.07
+53%
|
-0.11
-57%
|
0.03
N/A
|
-0.02
N/A
|
-0.19
-850%
|
-0.32
-68%
|
|
Switch to:
Switch to:
See Also
Discover More
